Synaptic Competition

Synaptic Competition enters the Adult Cognitive Disease corpus through the work of Zhen Huang (submission 28), and is indexed here as one of the concepts that submission puts to work.

The argument it belongs to

Zhen Huang's submission is summarised in this corpus as:

The Axonal Competition Hypothesis proposes that amyloid-beta is an evolutionarily conserved signaling molecule mediating activity-dependent synaptic competition via concentration-dependent duality: protective monomers shield active synapses through PI3K/Akt signaling while toxic oligomers prune weaker competitors via PirB/NgR receptors. Pathological aggregation depletes the protective monomer pool, disinhibiting microglial TNF-alpha release which inhibits neuronal V-ATPase.

Where it sits

The submission scores against the framework's convergence nodes as: compensatory paradigm 9 · endosomal nexus 8 · cytoskeletal collapse 7 · neuroimmune interface 7 · ApoE4 hub 2.

Its declared subject matter: synaptic-competition, antimicrobial-peptide, quorum-sensing, neuroinflammation, microglial-regulation, endocytosis, monomer-oligomer-duality, evolutionary-biology, TNF-alpha, V-ATPase.

Use in the corpus

Referred to by 3 documents in the research corpus, including research/collapse-trilogy/INTEGRATION_MEMO_2026-05-22.md, research/collapse-trilogy/convergent-synaptic/ONS_SynapticCollapse_Thesis.md, research/quiet-death/Synaptic_Subtraction_and_Neuronal_Death.md.

Named by the same submission

5 other concepts enter the corpus through the same paper, so they cover adjacent ground: Endolysosomal Dysfunction · Innate Immunity · Microglial Immunometabolism · Neuroinflammation · Synaptic Pathology.

Axonal Transport · Ferroptosis · Tau Pathology · Autophagy · cognitive resilience


Assembled from the corpus rather than written: the summary is quoted from the submission that named it; the node scores are read from its dossier; the reference count is measured across the research corpus. It has not yet been expanded into an article.

Last reviewed 15 August 2026.

Important noticeThis is a research platform, not a medical site. Nothing here is medical advice, a diagnosis, or a treatment recommendation, and none of it has been reviewed by a regulator. The drugs, doses and trials discussed are research literature, not prescriptions. If dementia affects you or someone you care about, speak to a doctor.

Compiled from the knowledge base and the research corpus under the Organic Network Synthesis methodology · the research corpus of Adult Cognitive Disease · the seven monographs are here. 2026.

827 interlinked articles · 120 papers in full · 53 as typeset PDFs · 635 concepts · 7 convergence nodes · 5 temporal stages.

Discussion

Corrections and disagreements are welcome here, and citation corrections most of all. Posting needs a GitHub account. Please read Taking Part first — in particular, nothing here is medical advice.